China vs Iran: Average cost of tuberculosis treatment multi drug resistant
China
20,028
in 2024
Iran
28,730
in 2022
China rank
4th
Iran rank
3rd
Average cost of tuberculosis treatment multi drug resistant over time
- China
- Iran
How they compare
Iran currently reports 28,730 against 20,028 in China, a difference of 8,702.
That makes Iran's figure about 1.4 times China's.
The two have swapped places 4 times across 6 shared years of data; in 2017 it was Iran ahead.
China ranks 4th and Iran ranks 3rd of 92 countries.
Across the 2 decades both report, China averaged higher in 1 and Iran in 1.
Head to head by decade
| Decade | China | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,001 | 8,842 | 2,841 | Iran |
| 2020s | 21,263 | 20,687 | 576.33 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, China or Iran?
- Iran, at 28,730 against 20,028 in China as of 2022.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between China and Iran?
- 8,702, with Iran ahead.
- How many years of comparable data are there for China and Iran?
- 6 years are reported by both, from 2017 to 2022.
- How do China and Iran rank globally for average cost of tuberculosis treatment multi drug resistant?
- China ranks 4th and Iran ranks 3rd of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.